Ongoing studies characterizing the effects of CD71+ erythroid cells on neonatal innate and adaptive immunity and assessing potentially beneficial effects of these cells on prevention of NEC will inform efforts to modify or enhance immune response in this most vulnerable population. This evidence concerns the gene TFRC and necrotizing enterocolitis.